4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-16-012180
CIK 0001316175operating
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 7:33 PM ET
Size
5.4 KB
Accession
0001214659-16-012180
Insider Transaction Report
Form 4
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Award
Stock option (right to buy)
2016-06-09+170,000→ 170,000 totalExercise: $3.52Exp: 2026-06-09→ Common Stock (170,000 underlying)
Footnotes (1)
- [F1]The option shall vest and become exercisable, if at all, in installments upon the achievement of certain performance milestones as approved by the Company's Board of Directors.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 7:33 PM ET
- Size
- 5.4 KB